〔閲覧〕【著作】(里見 志帆/[高石 和美]/[川人 伸次]/[北畑 洋]/[田中 克哉]/Hiroyuki Kinoshita/Roles of clinical sevoflurane doses as both the protein kinase C activator and NADPH oxidase inhibitor upon thromboxane A2 application in the rat arteries./American Society of Anesthesiologists 2017 Annual Meeting)
(英) Roles of clinical sevoflurane doses as both the protein kinase C activator and NADPH oxidase inhibitor upon thromboxane A2 application in the rat arteries. (日)
[継承]
○副題(任意):
○要約(任意):
○キーワード(推奨):
○発行所(推奨):
○誌名(必須):
□
(英) American Society of Anesthesiologists 2017 Annual Meeting (日)(読)
○ISSN(任意):
[継承]
○巻(必須):
□
[継承]
○号(必須):
□
[継承]
○頁(必須):
○都市(必須):
○年月日(必須):
□
西暦 2017年 10月 22日 (平成 29年 10月 22日)
[継承]
○URL(任意):
○DOI(任意):
○PMID(任意):
○CRID(任意):
○WOS(任意):
○Scopus(任意):
○評価値(任意):
○被引用数(任意):
○指導教員(推奨):
○備考(任意):
標準的な表示
和文冊子 ●
Satomi Shiho, Kazumi Takaishi, Shinji Kawahito, Hiroshi Kitahata, Katsuya TanakaandKinoshita Hiroyuki : Roles of clinical sevoflurane doses as both the protein kinase C activator and NADPH oxidase inhibitor upon thromboxane A2 application in the rat arteries., American Society of Anesthesiologists 2017 Annual Meeting, (頁), (都市), Oct. 2017.
欧文冊子 ●
Satomi Shiho, Kazumi Takaishi, Shinji Kawahito, Hiroshi Kitahata, Katsuya TanakaandKinoshita Hiroyuki : Roles of clinical sevoflurane doses as both the protein kinase C activator and NADPH oxidase inhibitor upon thromboxane A2 application in the rat arteries., American Society of Anesthesiologists 2017 Annual Meeting, (頁), (都市), Oct. 2017.
関連情報
Number of session users = 0, LA = 2.62, Max(EID) = 437938, Max(EOID) = 1161294.